Design
Review
Authors
Loading...
Current hERG safety assays may miss long-term trafficking defects; leaves open whether updated screens are needed to reduce pro-arrhythmic drug risk.
Key points are not available for this paper at this time.
Heyden et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: